ID ZN473_HUMAN Reviewed; 871 AA. AC Q8WTR7; A8K8T7; Q9ULS9; Q9Y4Q7; DT 31-AUG-2004, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2002, sequence version 1. DT 27-MAR-2024, entry version 183. DE RecName: Full=Zinc finger protein 473; DE AltName: Full=Zinc finger protein 100 homolog; DE Short=Zfp-100; GN Name=ZNF473; Synonyms=KIAA1141, ZFP100; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH SLBP/PRE-MRNA RP COMPLEX. RX PubMed=11782445; DOI=10.1101/gad.932302; RA Dominski Z., Erkmann J.A., Yang X., Sanchez R., Marzluff W.F.; RT "A novel zinc finger protein is associated with U7 snRNP and interacts with RT the stem-loop binding protein in the histone pre-mRNP to stimulate 3'-end RT processing."; RL Genes Dev. 16:58-71(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=10574461; DOI=10.1093/dnares/6.5.329; RA Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.; RT "Characterization of cDNA clones selected by the GeneMark analysis from RT size-fractionated cDNA libraries from human brain."; RL DNA Res. 6:329-336(1999). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Testis; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Eye; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 486-871. RC TISSUE=Testis; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [7] RP INTERACTION WITH LSM11. RC TISSUE=Cervix carcinoma; RX PubMed=12975319; DOI=10.1101/gad.274403; RA Pillai R.S., Grimmler M., Meister G., Will C.L., Luehrmann R., Fischer U., RA Schuemperli D.; RT "Unique Sm core structure of U7 snRNPs: assembly by a specialized SMN RT complex and the role of a new component, Lsm11, in histone RNA RT processing."; RL Genes Dev. 17:2321-2333(2003). RN [8] RP INTERACTION WITH LSM11. RX PubMed=15824063; DOI=10.1093/nar/gki516; RA Azzouz T.N., Gruber A., Schuemperli D.; RT "U7 snRNP-specific Lsm11 protein: dual binding contacts with the 100 kDa RT zinc finger processing factor (ZFP100) and a ZFP100-independent function in RT histone RNA 3'-end processing."; RL Nucleic Acids Res. 33:2106-2117(2005). RN [9] RP FUNCTION. RX PubMed=16914750; DOI=10.1128/mcb.00391-06; RA Wagner E.J., Marzluff W.F.; RT "ZFP100, a component of the active U7 snRNP limiting for histone pre-mRNA RT processing, is required for entry into S phase."; RL Mol. Cell. Biol. 26:6702-6712(2006). RN [10] RP FUNCTION, INTERACTION WITH LSM11, AND SUBCELLULAR LOCATION. RX PubMed=16714279; DOI=10.1261/rna.2606; RA Wagner E.J., Ospina J.K., Hu Y., Dundr M., Matera A.G., Marzluff W.F.; RT "Conserved zinc fingers mediate multiple functions of ZFP100, a U7snRNP RT associated protein."; RL RNA 12:1206-1218(2006). RN [11] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-148; LYS-419; LYS-549; LYS-558 RP AND LYS-635, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE RP ANALYSIS]. RX PubMed=28112733; DOI=10.1038/nsmb.3366; RA Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C., RA Nielsen M.L.; RT "Site-specific mapping of the human SUMO proteome reveals co-modification RT with phosphorylation."; RL Nat. Struct. Mol. Biol. 24:325-336(2017). RN [12] RP STRUCTURE BY NMR OF 205-841. RG RIKEN structural genomics initiative (RSGI); RT "Solution structure of the C2H2 type zinc finger region of human zinc RT finger protein 473."; RL Submitted (OCT-2007) to the PDB data bank. CC -!- FUNCTION: Involved in histone 3'-end pre-mRNA processing by associating CC with U7 snRNP and interacting with SLBP/pre-mRNA complex. Increases CC histone 3'-end pre-mRNA processing but has no effect on U7 snRNP CC levels, when overexpressed. Required for cell cycle progression from G1 CC to S phases. {ECO:0000269|PubMed:11782445, ECO:0000269|PubMed:16714279, CC ECO:0000269|PubMed:16914750}. CC -!- SUBUNIT: Interacts with the SLBP/pre-mRNA complex but not with SLBP CC alone. Interacts with LSM11 in a U7 snRNP-dependent manner. CC {ECO:0000269|PubMed:11782445, ECO:0000269|PubMed:12975319, CC ECO:0000269|PubMed:15824063, ECO:0000269|PubMed:16714279}. CC -!- INTERACTION: CC Q8WTR7; Q8WTP8: AEN; NbExp=5; IntAct=EBI-751409, EBI-8637627; CC Q8WTR7; P49760: CLK2; NbExp=3; IntAct=EBI-751409, EBI-750020; CC Q8WTR7; P49761: CLK3; NbExp=3; IntAct=EBI-751409, EBI-745579; CC Q8WTR7; Q6P158: DHX57; NbExp=3; IntAct=EBI-751409, EBI-1051531; CC Q8WTR7; Q9NWQ4: GPATCH2L; NbExp=4; IntAct=EBI-751409, EBI-5666657; CC Q8WTR7; P60014: KRTAP10-10; NbExp=3; IntAct=EBI-751409, EBI-11955579; CC Q8WTR7; P60410: KRTAP10-8; NbExp=6; IntAct=EBI-751409, EBI-10171774; CC Q8WTR7; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-751409, EBI-10172052; CC Q8WTR7; Q8WWY3: PRPF31; NbExp=3; IntAct=EBI-751409, EBI-1567797; CC Q8WTR7; P98175: RBM10; NbExp=3; IntAct=EBI-751409, EBI-721525; CC Q8WTR7; D3DU92: RNPS1; NbExp=3; IntAct=EBI-751409, EBI-10176640; CC Q8WTR7; Q8WV44: TRIM41; NbExp=5; IntAct=EBI-751409, EBI-725997; CC Q8WTR7; P15622-3: ZNF250; NbExp=3; IntAct=EBI-751409, EBI-10177272; CC Q8WTR7; Q9H9D4: ZNF408; NbExp=3; IntAct=EBI-751409, EBI-347633; CC Q8WTR7; Q6ZNH5: ZNF497; NbExp=3; IntAct=EBI-751409, EBI-10486136; CC Q8WTR7; Q3KQV3: ZNF792; NbExp=5; IntAct=EBI-751409, EBI-10240849; CC Q8WTR7; Q96EG3: ZNF837; NbExp=3; IntAct=EBI-751409, EBI-11962574; CC Q8WTR7; O43309: ZSCAN12; NbExp=3; IntAct=EBI-751409, EBI-1210440; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16714279}. CC Note=Stable component of Cajal bodies (CBs). Colocalizes with SMN, CC coilin and U7 snRNA. CC -!- DOMAIN: The C2H2-type zinc finger 2 to 6 are necessary and sufficient CC for discrete Cajal bodies localization. The C2H2-type zinc finger 5 to CC 10 are necessary and sufficient for interaction with LSM11. The C2H2- CC type zinc finger 2 to 8 are necessary for interaction with the SLBP/RNA CC complex in the histone pre-mRNAs. The C2H2-type zinc finger 2 to 10 CC confer activity in histone pre-mRNA processing. CC -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein CC family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA86455.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF454744; AAL51029.1; -; mRNA. DR EMBL; AB032967; BAA86455.1; ALT_INIT; mRNA. DR EMBL; AK292452; BAF85141.1; -; mRNA. DR EMBL; CH471177; EAW52593.1; -; Genomic_DNA. DR EMBL; BC018612; AAH18612.1; -; mRNA. DR EMBL; AL080143; CAB45736.1; -; mRNA. DR CCDS; CCDS33077.1; -. DR PIR; T12527; T12527. DR RefSeq; NP_001006657.1; NM_001006656.3. DR RefSeq; NP_001295353.1; NM_001308424.2. DR RefSeq; NP_056243.1; NM_015428.3. DR PDB; 2EMB; NMR; -; A=342-372. DR PDB; 2EMC; NMR; -; A=641-673. DR PDB; 2EME; NMR; -; A=725-757. DR PDB; 2EOU; NMR; -; A=370-400. DR PDB; 2EOX; NMR; -; A=315-345. DR PDB; 2EOY; NMR; -; A=557-589. DR PDB; 2EOZ; NMR; -; A=809-841. DR PDB; 2YRH; NMR; -; A=699-729. DR PDB; 2YRJ; NMR; -; A=781-813. DR PDB; 2YSV; NMR; -; A=755-783. DR PDB; 2YTD; NMR; -; A=426-458. DR PDB; 2YTE; NMR; -; A=484-512. DR PDB; 2YTT; NMR; -; A=204-236. DR PDB; 2YU5; NMR; -; A=669-699. DR PDBsum; 2EMB; -. DR PDBsum; 2EMC; -. DR PDBsum; 2EME; -. DR PDBsum; 2EOU; -. DR PDBsum; 2EOX; -. DR PDBsum; 2EOY; -. DR PDBsum; 2EOZ; -. DR PDBsum; 2YRH; -. DR PDBsum; 2YRJ; -. DR PDBsum; 2YSV; -. DR PDBsum; 2YTD; -. DR PDBsum; 2YTE; -. DR PDBsum; 2YTT; -. DR PDBsum; 2YU5; -. DR AlphaFoldDB; Q8WTR7; -. DR SMR; Q8WTR7; -. DR BioGRID; 117398; 27. DR IntAct; Q8WTR7; 24. DR STRING; 9606.ENSP00000472808; -. DR iPTMnet; Q8WTR7; -. DR PhosphoSitePlus; Q8WTR7; -. DR BioMuta; ZNF473; -. DR DMDM; 51702187; -. DR EPD; Q8WTR7; -. DR jPOST; Q8WTR7; -. DR MassIVE; Q8WTR7; -. DR PaxDb; 9606-ENSP00000472808; -. DR PeptideAtlas; Q8WTR7; -. DR ProteomicsDB; 74591; -. DR Antibodypedia; 32254; 144 antibodies from 21 providers. DR DNASU; 25888; -. DR Ensembl; ENST00000270617.8; ENSP00000270617.3; ENSG00000142528.16. DR Ensembl; ENST00000391821.6; ENSP00000375697.1; ENSG00000142528.16. DR Ensembl; ENST00000595661.5; ENSP00000472808.1; ENSG00000142528.16. DR GeneID; 25888; -. DR KEGG; hsa:25888; -. DR MANE-Select; ENST00000270617.8; ENSP00000270617.3; NM_015428.4; NP_056243.1. DR UCSC; uc002prm.4; human. DR AGR; HGNC:23239; -. DR CTD; 25888; -. DR GeneCards; ZNF473; -. DR HGNC; HGNC:23239; ZNF473. DR HPA; ENSG00000142528; Tissue enriched (testis). DR MIM; 617908; gene. DR neXtProt; NX_Q8WTR7; -. DR OpenTargets; ENSG00000142528; -. DR PharmGKB; PA134987987; -. DR VEuPathDB; HostDB:ENSG00000142528; -. DR eggNOG; KOG1721; Eukaryota. DR GeneTree; ENSGT00840000130048; -. DR HOGENOM; CLU_002678_27_0_1; -. DR InParanoid; Q8WTR7; -. DR OMA; YSCAKCK; -. DR OrthoDB; 5249044at2759; -. DR PhylomeDB; Q8WTR7; -. DR TreeFam; TF350932; -. DR PathwayCommons; Q8WTR7; -. DR Reactome; R-HSA-111367; SLBP independent Processing of Histone Pre-mRNAs. DR Reactome; R-HSA-212436; Generic Transcription Pathway. DR Reactome; R-HSA-73856; RNA Polymerase II Transcription Termination. DR Reactome; R-HSA-77588; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs. DR SignaLink; Q8WTR7; -. DR BioGRID-ORCS; 25888; 8 hits in 1178 CRISPR screens. DR EvolutionaryTrace; Q8WTR7; -. DR GeneWiki; ZNF473; -. DR GenomeRNAi; 25888; -. DR Pharos; Q8WTR7; Tbio. DR PRO; PR:Q8WTR7; -. DR Proteomes; UP000005640; Chromosome 19. DR RNAct; Q8WTR7; Protein. DR Bgee; ENSG00000142528; Expressed in right uterine tube and 142 other cell types or tissues. DR ExpressionAtlas; Q8WTR7; baseline and differential. DR GO; GO:0015030; C:Cajal body; IDA:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IBA:GO_Central. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central. DR GO; GO:0006398; P:mRNA 3'-end processing by stem-loop binding and cleavage; IDA:UniProtKB. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central. DR CDD; cd07765; KRAB_A-box; 1. DR Gene3D; 3.30.160.60; Classic Zinc Finger; 20. DR InterPro; IPR001909; KRAB. DR InterPro; IPR036051; KRAB_dom_sf. DR InterPro; IPR036236; Znf_C2H2_sf. DR InterPro; IPR013087; Znf_C2H2_type. DR PANTHER; PTHR47772:SF4; REDUCED EXPRESSION 2-RELATED; 1. DR PANTHER; PTHR47772; ZINC FINGER PROTEIN 200; 1. DR Pfam; PF01352; KRAB; 1. DR Pfam; PF00096; zf-C2H2; 15. DR SMART; SM00349; KRAB; 1. DR SMART; SM00355; ZnF_C2H2; 20. DR SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 11. DR SUPFAM; SSF109640; KRAB domain (Kruppel-associated box); 1. DR PROSITE; PS50805; KRAB; 1. DR PROSITE; PS00028; ZINC_FINGER_C2H2_1; 18. DR PROSITE; PS50157; ZINC_FINGER_C2H2_2; 20. DR Genevisible; Q8WTR7; HS. PE 1: Evidence at protein level; KW 3D-structure; DNA-binding; Isopeptide bond; Metal-binding; Nucleus; KW Reference proteome; Repeat; Ubl conjugation; Zinc; Zinc-finger. FT CHAIN 1..871 FT /note="Zinc finger protein 473" FT /id="PRO_0000047604" FT DOMAIN 6..75 FT /note="KRAB" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00119" FT ZN_FING 209..231 FT /note="C2H2-type 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 265..286 FT /note="C2H2-type 2; degenerate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 320..342 FT /note="C2H2-type 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 347..369 FT /note="C2H2-type 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 375..397 FT /note="C2H2-type 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 403..425 FT /note="C2H2-type 6; degenerate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 431..453 FT /note="C2H2-type 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 459..481 FT /note="C2H2-type 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 487..509 FT /note="C2H2-type 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 515..537 FT /note="C2H2-type 10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 562..584 FT /note="C2H2-type 11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 591..613 FT /note="C2H2-type 12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 646..668 FT /note="C2H2-type 13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 674..696 FT /note="C2H2-type 14" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 702..724 FT /note="C2H2-type 15" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 730..752 FT /note="C2H2-type 16" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 758..780 FT /note="C2H2-type 17" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 786..808 FT /note="C2H2-type 18" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 814..836 FT /note="C2H2-type 19" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 842..864 FT /note="C2H2-type 20" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT REGION 47..81 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 140..164 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 290..318 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 312..552 FT /note="Interaction with SLBP/pre-mRNA complex" FT COMPBIAS 290..317 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT CROSSLNK 148 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT CROSSLNK 419 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT CROSSLNK 549 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT CROSSLNK 558 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT CROSSLNK 635 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT VARIANT 59 FT /note="S -> G (in dbSNP:rs10419876)" FT /id="VAR_052839" FT VARIANT 74 FT /note="S -> G (in dbSNP:rs10419911)" FT /id="VAR_052840" FT VARIANT 164 FT /note="T -> M (in dbSNP:rs16981705)" FT /id="VAR_052841" FT VARIANT 309 FT /note="E -> G (in dbSNP:rs16981706)" FT /id="VAR_052842" FT VARIANT 654 FT /note="T -> I (in dbSNP:rs10424809)" FT /id="VAR_052843" FT VARIANT 662 FT /note="S -> A (in dbSNP:rs10426374)" FT /id="VAR_052844" FT CONFLICT 486 FT /note="P -> A (in Ref. 6)" FT /evidence="ECO:0000305" FT CONFLICT 588 FT /note="V -> M (in Ref. 2; BAA86455)" FT /evidence="ECO:0000305" FT STRAND 212..214 FT /evidence="ECO:0007829|PDB:2YTT" FT HELIX 221..228 FT /evidence="ECO:0007829|PDB:2YTT" FT HELIX 230..233 FT /evidence="ECO:0007829|PDB:2YTT" FT STRAND 320..322 FT /evidence="ECO:0007829|PDB:2EOX" FT TURN 323..326 FT /evidence="ECO:0007829|PDB:2EOX" FT STRAND 327..332 FT /evidence="ECO:0007829|PDB:2EOX" FT HELIX 333..336 FT /evidence="ECO:0007829|PDB:2EOX" FT HELIX 339..342 FT /evidence="ECO:0007829|PDB:2EOX" FT STRAND 345..348 FT /evidence="ECO:0007829|PDB:2EMB" FT TURN 350..352 FT /evidence="ECO:0007829|PDB:2EMB" FT STRAND 355..357 FT /evidence="ECO:0007829|PDB:2EMB" FT HELIX 359..365 FT /evidence="ECO:0007829|PDB:2EMB" FT HELIX 366..369 FT /evidence="ECO:0007829|PDB:2EMB" FT STRAND 370..372 FT /evidence="ECO:0007829|PDB:2EOU" FT TURN 378..380 FT /evidence="ECO:0007829|PDB:2EOU" FT HELIX 387..397 FT /evidence="ECO:0007829|PDB:2EOU" FT STRAND 430..432 FT /evidence="ECO:0007829|PDB:2YTD" FT STRAND 434..436 FT /evidence="ECO:0007829|PDB:2YTD" FT STRAND 439..442 FT /evidence="ECO:0007829|PDB:2YTD" FT HELIX 443..453 FT /evidence="ECO:0007829|PDB:2YTD" FT TURN 490..492 FT /evidence="ECO:0007829|PDB:2YTE" FT HELIX 499..508 FT /evidence="ECO:0007829|PDB:2YTE" FT STRAND 565..567 FT /evidence="ECO:0007829|PDB:2EOY" FT STRAND 570..574 FT /evidence="ECO:0007829|PDB:2EOY" FT HELIX 575..581 FT /evidence="ECO:0007829|PDB:2EOY" FT STRAND 645..647 FT /evidence="ECO:0007829|PDB:2EMC" FT STRAND 649..651 FT /evidence="ECO:0007829|PDB:2EMC" FT STRAND 654..657 FT /evidence="ECO:0007829|PDB:2EMC" FT HELIX 658..665 FT /evidence="ECO:0007829|PDB:2EMC" FT TURN 666..670 FT /evidence="ECO:0007829|PDB:2EMC" FT STRAND 673..675 FT /evidence="ECO:0007829|PDB:2YU5" FT STRAND 677..680 FT /evidence="ECO:0007829|PDB:2YU5" FT STRAND 682..686 FT /evidence="ECO:0007829|PDB:2YU5" FT HELIX 687..695 FT /evidence="ECO:0007829|PDB:2YU5" FT TURN 705..707 FT /evidence="ECO:0007829|PDB:2YRH" FT STRAND 710..713 FT /evidence="ECO:0007829|PDB:2YRH" FT HELIX 714..721 FT /evidence="ECO:0007829|PDB:2YRH" FT TURN 722..724 FT /evidence="ECO:0007829|PDB:2YRH" FT STRAND 729..731 FT /evidence="ECO:0007829|PDB:2EME" FT STRAND 733..735 FT /evidence="ECO:0007829|PDB:2EME" FT STRAND 738..741 FT /evidence="ECO:0007829|PDB:2EME" FT HELIX 742..749 FT /evidence="ECO:0007829|PDB:2EME" FT HELIX 750..752 FT /evidence="ECO:0007829|PDB:2EME" FT STRAND 761..763 FT /evidence="ECO:0007829|PDB:2YSV" FT STRAND 768..771 FT /evidence="ECO:0007829|PDB:2YSV" FT HELIX 772..778 FT /evidence="ECO:0007829|PDB:2YSV" FT STRAND 789..791 FT /evidence="ECO:0007829|PDB:2YRJ" FT STRAND 794..797 FT /evidence="ECO:0007829|PDB:2YRJ" FT HELIX 798..805 FT /evidence="ECO:0007829|PDB:2YRJ" FT TURN 806..808 FT /evidence="ECO:0007829|PDB:2YRJ" FT STRAND 813..816 FT /evidence="ECO:0007829|PDB:2EOZ" FT TURN 817..820 FT /evidence="ECO:0007829|PDB:2EOZ" FT STRAND 821..825 FT /evidence="ECO:0007829|PDB:2EOZ" FT HELIX 826..836 FT /evidence="ECO:0007829|PDB:2EOZ" SQ SEQUENCE 871 AA; 100182 MW; 959AFB7C3C2D5456 CRC64; MAEEFVTLKD VGMDFTLGDW EQLGLEQGDT FWDTALDNCQ DLFLLDPPRP NLTSHPDGSE DLEPLAGGSP EATSPDVTET KNSPLMEDFF EEGFSQEIIE MLSKDGFWNS NFGEACIEDT WLDSLLGDPE SLLRSDIATN GESPTECKSH ELKRGLSPVS TVSTGEDSMV HNVSEKTLTP AKSKEYRGEF FSYSDHSQQD SVQEGEKPYQ CSECGKSFSG SYRLTQHWIT HTREKPTVHQ ECEQGFDRNA SLSVYPKTHT GYKFYVCNEY GTTFSQSTYL WHQKTHTGEK PCKSQDSDHP PSHDTQPGEH QKTHTDSKSY NCNECGKAFT RIFHLTRHQK IHTRKRYECS KCQATFNLRK HLIQHQKTHA AKTTSECQEC GKIFRHSSLL IEHQALHAGE EPYKCNERGK SFRHNSTLKI HQRVHSGEKP YKCSECGKAF HRHTHLNEHR RIHTGYRPHK CQECVRSFSR PSHLMRHQAI HTAEKPYSCA ECKETFSDNN RLVQHQKMHT VKTPYECQEC GERFICGSTL KCHESVHARE KQGFFVSGKI LDQNPEQKEK CFKCNKCEKT FSCSKYLTQH ERIHTRGVKP FECDQCGKAF GQSTRLIHHQ RIHSRVRLYK WGEQGKAISS ASLIKLQSFH TKEHPFKCNE CGKTFSHSAH LSKHQLIHAG ENPFKCSKCD RVFTQRNYLV QHERTHARKK PLVCNECGKT FRQSSCLSKH QRIHSGEKPY VCDYCGKAFG LSAELVRHQR IHTGEKPYVC QECGKAFTQS SCLSIHRRVH TGEKPYRCGE CGKAFAQKAN LTQHQRIHTG EKPYSCNVCG KAFVLSAHLN QHLRVHTQET LYQCQRCQKA FRCHSSLSRH QRVHNKQQYC L //